This CME Activity offers a practical review of neuropathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.
This post contains protected content. You must contact us to unlock it.
This CME activity is intended and designed to educate pathologists.
Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational Symposia designates this enduring material for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All activity participants are required to take a written or online test in order to be awarded credit. (Exam materials, if ordered, will be sent with your order.) All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.
AMA PRA Category 1 Credit(s)TM for these programs may be claimed until September 30, 2021.
This CME activity was planned and produced by Educational Symposia, the leader in diagnostic imaging education since 1975.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.
At the completion of this CME activity, subscribers should be able to:
No special educational preparation is required for this CME activity
01. Update of the WHO 2016 Classification Scheme for CNS Tumors – Arie Perry, M.D..mp4
02. New Immunohistochemical Biomarkers in Surgical Neuropathology – Arie Perry, M.D..mp4
03. Glial and Glioneuronal Neoplasms – Arie Perry, M.D..mp4
04. Embryonal Neoplasms of the CNS – Arie Perry, M.D..mp4
05. Meningioma Grading and Other Meningeal Neoplasms – Arie Perry, M.D..mp4
06. Peripheral Nerve Sheath Tumors – Arie Perry, M.D..mp4
07. Neuropathology Unknowns Part 1 – Case Based – Arie Perry, M.D..mp4
08. Neuropathology Unknowns Part 2 – Case Based – Arie Perry, M.D..mp4
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.